418374009: Product containing precisely dantron 5 milligram/1 milliliter and poloxamer 188 40 milligram/1 milliliter conventional release oral suspension (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Plant material-containing product\Plant agent product\Dantron-containing product\...

\Dantron-containing product in oral dose form\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension

\Dantron- and poloxamer 188-containing product\Dantron and poloxamer 188 only product\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension
\Dantron- and poloxamer 188-containing product\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension

\Medicinal product categorised by disposition\Surfactant-containing product\Nonionic surfactant-containing product\Poloxamer 188-containing product\...

\Poloxamer 188-containing product in oral dose form\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension

\Dantron- and poloxamer 188-containing product\Dantron and poloxamer 188 only product\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension
\Dantron- and poloxamer 188-containing product\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension

\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Lipoprotein-containing product\Poloxamer 188-containing product\Poloxamer 188-containing product in oral dose form\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Lipoprotein-containing product\Poloxamer 188-containing product\Dantron- and poloxamer 188-containing product\Dantron and poloxamer 188 only product\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Lipoprotein-containing product\Poloxamer 188-containing product\Dantron- and poloxamer 188-containing product\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension
\Medicinal product categorised by structure\Ketone-containing product\Anthraquinone laxative agent\Dantron-containing product in oral dose form\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension
\Medicinal product categorised by structure\Ketone-containing product\Dantron-containing product\Dantron-containing product in oral dose form\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension
\Medicinal product categorised by structure\Ketone-containing product\Dantron-containing product\Dantron- and poloxamer 188-containing product\Dantron and poloxamer 188 only product\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension
\Medicinal product categorised by structure\Ketone-containing product\Dantron-containing product\Dantron- and poloxamer 188-containing product\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension

\Medicinal product categorised by therapeutic role\Laxative agent\Anthraquinone laxative agent\Dantron-containing product in oral dose form\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension

\Product manufactured as oral dose form\Poloxamer 188-containing product in oral dose form\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension
\Product manufactured as oral dose form\Dantron-containing product in oral dose form\Dantron- and poloxamer 188-containing product in oral dose form\Dantron and poloxamer 188 only product in oral dose form\Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension

Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3694430010 Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension en Synonym Active Initial character case insensitive SNOMED CT core

3694431014 Product containing precisely dantron 5 milligram/1 milliliter and poloxamer 188 40 milligram/1 milliliter conventional release oral suspension (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

3694433012 Danthron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension en Synonym Active Initial character case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Plays role	Laxative therapeutic role	true	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Plays role	Stool softener therapeutic role	false	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Is a	Dantron and poloxamer 188 only product in oral dose form	true	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Is a	Dantron- and poloxamer 188-containing product	false	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has active ingredient	Danthron	false	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has manufactured dose form	Oral suspension	true	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has active ingredient	Poloxamer 188	false	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Is a	Product manufactured as oral dose form	false	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Is a	Dantron- and poloxamer 188-containing product in oral dose form	false	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has concentration strength denominator value	1	false	Inferred relationship	Some	2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has concentration strength denominator value	1	false	Inferred relationship	Some	1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Count of base of active ingredient	2	false	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has precise active ingredient	Poloxamer 188	true	Inferred relationship	Some	2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has precise active ingredient	Danthron	true	Inferred relationship	Some	1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has BoSS	Poloxamer 188	true	Inferred relationship	Some	2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has concentration strength numerator value	40	false	Inferred relationship	Some	2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has BoSS	Danthron	true	Inferred relationship	Some	1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	Has concentration strength numerator value	5	false	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3694430010	Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	en	Synonym	Active	Initial character case insensitive	SNOMED CT core
3694431014	Product containing precisely dantron 5 milligram/1 milliliter and poloxamer 188 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3694433012	Danthron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	en	Synonym	Active	Initial character case insensitive	SNOMED CT core